Advertisements


The Daily Biotech Pulse: IPOs, Puma"s Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 2) read more.....»»

Category: blogSource: benzingaOct 3rd, 2019

The Daily Biotech Pulse: IPOs, Puma"s Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 2) read more.....»»

Category: blogSource: benzingaOct 3rd, 2019

The Daily Biotech Pulse: FibroGen Kidney Disease Trial Disappoints, Medtronic To Buy Titan Spine, Puma"s Weak Breast Cancer Drug Sales

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 9) Alcon AG (NYSE: ALC) ANI Pharmaceuticals Inc (NASDA.....»»

Category: earningsSource: benzingaMay 10th, 2019

The Daily Biotech Pulse: FibroGen Kidney Disease Trial Disappoints, Medtronic To Buy Titan Spine, Puma"s Weak Breast Cancer Drug Sales

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 9) read more.....»»

Category: blogSource: benzingaMay 10th, 2019

The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene"s Blood Cancer Drug Gets Approval

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The .....»»

Category: earningsSource: benzingaNov 15th, 2019

The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene"s Blood Cancer Drug Gets Approval

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 14) 0 read more.....»»

Category: blogSource: benzingaNov 15th, 2019

The Daily Biotech Pulse: Gilead"s Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Oct. 26) read more.....»»

Category: blogSource: benzingaOct 26th, 2018

The Daily Biotech Pulse: Eli Lily Revenues Trail Estimates, Moderna Gets Fast Track Designation, MacroGenics" Lukewarm Breast Cancer Data

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 22) read more.....»»

Category: blogSource: benzingaOct 23rd, 2019

The Daily Biotech Pulse: Eli Lily Revenues Trail Estimates, Moderna Gets Fast Track Designation, MacroGenics" Lukewarm Breast Cancer Data

Here's a roundup of top developments in the biot.....»»

Category: earningsSource: benzingaOct 23rd, 2019

The Daily Biotech Pulse: PhaseBio Leaps On Trial Results, Pacira Set To Join SmallCap 600 Index, Positive Readout For Amgen"s Blood Cancer Drug

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 24) read more.....»»

Category: blogSource: benzingaSep 25th, 2019

The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 18) read more.....»»

Category: blogSource: benzingaSep 19th, 2019

The Daily Biotech Pulse: Ardelyx Awaits Ruling On Constipation Drug, Double Dose Of Good News For Roche, Tocagen Flunks Brain Cancer Study

The following is a roundup of top developments in the biotech space over the last 24 hours.  Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 11.) read more.....»»

Category: blogSource: benzingaSep 12th, 2019

The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Bi.....»»

Category: earningsSource: benzingaAug 16th, 2019

The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 15) read more.....»»

Category: blogSource: benzingaAug 16th, 2019

The Daily Biotech Pulse: Vascepa Delay Sends Amarin Reeling, Eidos Jumps On Buyout Offer, Nektar"s Bitter Q2

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 8) read more.....»»

Category: blogSource: benzingaAug 9th, 2019

The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 1) read more.....»»

Category: blogSource: benzingaAug 1st, 2019

The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer"s Prostate Cancer Drug Passes FDA Muster

Here's a roundup of top developments in the biotech space over the last 24 hours. Scali.....»»

Category: earningsSource: benzingaJul 31st, 2019

The Daily Biotech Pulse: FDA Approves Karyopharm"s Blood Cancer Treatment, Grifols" Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight

The following is a roundup of the top developments in the biotech space over the last 24 hours.  Scaling The Peaks (Biotech stocks that hit 52-week highs July 3.) • Abbott Laboratories (NYSE: ABT) read more.....»»

Category: blogSource: benzingaJul 5th, 2019

Puma Biotech Submits sNDA for Breast Cancer Drug Nerlynx

Puma Biotech (PBYI) files an sNDA for the nod of Nerlynx in combination with Xeloda to treat patients with HER2-positive metastatic breast cancer, having failed two or m.....»»

Category: dealsSource: nytJul 2nd, 2019

The Daily Biotech Pulse: Mixed Results For Merck"s Keytruda In Stomach Cancer; Roche"s Spark-Buy Delayed, Teva Recalls Hypertension Drug

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 25) read more.....»»

Category: blogSource: benzingaApr 26th, 2019

Puma Biotech Out-Licenses Nerlynx Rights in Europe, Stock Down

Puma Biotech (PBYI) out-licenses development and marketing rights to its breast cancer drug Nerlynx to Pierre Fa.....»»

Category: dealsSource: nytApr 2nd, 2019